AAAAAA

   
Results: 1-2 |
Results: 2
THE DISCOVERY OF CP-96,021 AND CP-96,486, BALANCED, COMBINED, POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 (LTD(4)) PLATELET ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONISTS/
Authors: MARFAT A CHAMBERS R CHENG J COOPER K DAMON D DELEHUNT J EGGLER J MASAMUNE H MELVIN L WATSON J
Citation: A. Marfat et al., THE DISCOVERY OF CP-96,021 AND CP-96,486, BALANCED, COMBINED, POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 (LTD(4)) PLATELET ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONISTS/, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1377-1382
DEVELOPMENT OF CROSS-TOLERANCE BETWEEN DELTA(9)-TETRAHYDROCANNABINOL,CP-55,940 AND WIN-55,212
Authors: FAN F COMPTON DR WARD S MELVIN L MARTIN BR
Citation: F. Fan et al., DEVELOPMENT OF CROSS-TOLERANCE BETWEEN DELTA(9)-TETRAHYDROCANNABINOL,CP-55,940 AND WIN-55,212, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1383-1390
Risultati: 1-2 |